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Abstract.  Two mouse monoclonal antibodies gener- 
ated against human placental homogenate were found 
to react specifically with human complement compo- 
nent C3.  In immunofluorescence of human tissues, 
these antibodies gave a bright linear staining outlining 
the glomerular basement membrane of the adult kid- 
ney and the trophoblast basement membrane of 
placenta.  An identical staining pattern was observed 
with a  rabbit C3d antiserum which also prevented 
binding of the monoclonal antibodies to tissue sec- 
tions.  Only negligible basement membrane staining 
was observed in the same tissues with antisera to hu- 
man C3c, C5, IgG, IgA, or IgM.  When interactions of 
C3 with basement membrane proteins were tested in 
enzyme immunoassays and column chromatography, 
C3(H20) was found to bind efficiently to solid-phase 
laminin.  Native C3 from fresh plasma did not bind to 
laminin but C3 from plasma treated with methylamine 
bound efficiently.  When C3 was cleaved with trypsin, 
C3b and C3d but not C3c bound to laminin- 
Sepharose.  The interaction of C3 and laminin was in- 
hibited by soluble laminin  and by high ionic strength. 
The results indicate that C3d,  a biologically active 
breakdown product of C3, can be found in glomerular 
and placental basement membranes in the absence of 
signs for ongoing local complement activation or im- 
mune complex deposition. It is possible that binding 
affinities between C3 and basement membrane 
molecules, especially laminin,  are involved in the 
retention of C3d at these simms. Such interactions be- 
tween C3 and components of the glomerular basement 
membrane could play important  roles in complement- 
related pathological processes of the glomerulus. 
C 
OMPLEMENT plays a major role in the defense against 
infections  by microorganisms  (2, 30, 33).  The third 
component of complement, C3, participates  in both 
the  antibody-dependent  classical  (32)  and  the  antibody- 
independent  alternative  pathways  of  complement  activa- 
tion (27). 
Proteolytic cleavage of C3 (185 kD) gives rise to fragments 
that  display important  biological  activities  not associated 
with  intact  C3.  Initial  cleavage  releases  C3a  (9  kD)-a 
vasoactive peptide and a mediator of inflammation  (7,  19). 
The liberated C3b (176 kD), when bound to cell surfaces or 
foreign particles (22, 37), may initiate formation of the mem- 
brane attack complex (27).  Eventually,  the bound C3b is 
cleaved and C3c (140 kD) is lost into the fluid phase,  while 
C3dg (39 kD) remains bound (8, 20). Tryptic cleavage of C3 
yields a slightly  smaller fragment,  the C3d (35 kD). 
A low level of C3dg is present in normal human plasma, 
and higher  levels are seen in disorders associated with in- 
creased complement consumption (28). Recently, it has been 
reported that C3d has immunomodulatory functions in addi- 
tion to its role in complement activation.  C3d-K, a kallikrein 
cleavage fragment of C3,  inhibits  proliferation  of lympho- 
cytes and other cells (38), induces leukocytosis (17), and en- 
hances enzyme secretion by macrophages,  whereas C3d may 
also act as a lymphocyte growth factor (24).  In the present 
study, we show that C3d is present in many trophoblast base- 
ment  membranes  and  often  in  the  glomerular  basement 
membrane. When the interaction of C3 with basement mem- 
brane proteins  was tested in  vitro,  C3  showed  particular 
affinity to laminin.  From trypsin digests of C3, only the C3b 
and C3d fragments  bound to laminin. 
Materials and Methods 
Immunoprecipitation of CeU Culture Media 
Human tumor cell lines and normal fibroblastic cells obtained from Ameri- 
can Type Culture Collection (Rockville, MD) and from other sources were 
grown in Eagle's minimum essential medium supplemented with t0% fetal 
calf serum. For immunoprecipitafion, subconfluent cultures were incubated 
for 24 h in methionine-free  minimum essential medium supplemented with 
glutamine, ITS (insulin/transferfin/selenium; Collaborative Research, Inc., 
Waltham, MA), and 100 ~Ci/ml of [35Slmethionine  (1,100 Ci/mmol; New 
England  Nuclear,  Boston,  MA).  Culture  medium  was  collected,  cen- 
trifuged, and made 0.5 M with NaC1,  0.1 mM with phenylmethylsulf~nyl 
fluoride, 0.1% with Tween 20, and 0.1 M  with Tris-HCi, pH 7.0. Protein 
A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ), which had been 
preincubated with an excess of rabbit anti-mouse IgG antiserum, was satu- 
rated with hybridoma ascitic fluid and washed. 1 ml of culture medium was 
then incubated with the Sepharose beads for 3 h at room temperature. The 
Sepharose beads were washed five times with 0.5 M NaCl and 0.1% Tween 
in 0.05 M Tris-HCl, pH 7.2. The samples were then boiled in SDS PAGE 
sample buffer and 2-mercaptoethanol for 5 min and analyzed by SDS PAGE. 
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Human placentas were obtained from cesarean sections or normal-term 
deliveries.  Other human tissues were from autopsy  cases with no history 
or findings of a pathologic process in the organ studied.  Newborn monkey 
tissues were obtained from the Primate Research Center (Alamogordo, 
NM).  After being transported under cooled conditions, the tissues were 
snap-frozen  in liquid nitrogen and 6-1~m frozen  sections made,  air dried, 
and fixed in cold acetone. 
Mouse  tissues  were  obtained from adult and  newborn BALB/c  and 
C57B1  mice (Bantam and Kingman Inc., Fremont, CA).  Adult mice re- 
ceived a tail vein injection of 17 Ixg phenylmethylsulfonyl  fluoride and 1.7 
nag EDTA in 0.5 ml of phosphate-buffered  saline (Pi/NaCI) (for 0.2 mM 
phenylmethylsulfonyl  fluoride and 10 mM EDTA in an estimated circulating 
volume of 5 ml) 10 min before sacrifice. Control mice received no injection. 
The mice were then anesthetized with methoxyflurane  inhalation and the 
kidneys were snap-frozen in situ by using liquid nitrogen.  Similarly, close- 
to-term  placentas  were  obtained  from  BALB/c  mice.  Also,  newborn 
BALB/c  mouse  kidneys  were  snap-frozen.  Frozen  mouse  tissues  were 
processed as human and monkey tissues. 
For immunofluorescence,  sections were treated for 2 h with hybridoma 
culture medium diluted  1:2 or ascitic fluid diluted 1:100-500, followed by 
fluorescein  isothiocyanate  (FITC)-conjugated I goat anti-mouse IgG (Cap- 
pel Laboratories,  Cochranville, PA) at 1:40 dilution. Staining of sections 
with rabbit antisera was performed as described (23). The specimens were 
observed in a  Zeiss  microscope equipped  for  phase  contrast and  epi- 
illumination.  For  double  staining,  sections were treated  as  above  with 
monoclonal antibodies followed by FITC-conjugated  goat anti-mouse IgG, 
and then with rabbit anti-human C3d antiserum at 1:100 dilution followed 
by tetramethylrhodamine  isothiocyanate (TRITC)-conjugated  goat anti-rab- 
bit IgG (Cappel  Laboratories)  at 1:40 dilution. Inhibition of the binding of 
monoclonal antibodies to tissue sections was carried out by pretreating the 
sections  with rabbit anti-human C3d antiserum at 1:10 dilution overnight 
and subsequently staining with the monoclonal antibodies as above. For elu- 
tion experiments, unfixed  frozen sections  were  treated with  1 M  NaC1, 
1 M acetic acid, 6 M guanidine,  or 8 M urea for 30-180 rain, washed,  air 
dried, fixed with acetone,  and stained  for C3d and laminin. 
For the studies on the binding of human C3 to cell cultures,  1 mg/mi of 
C3 (Behring Diagnostics,  San Diego,  CA) was incubated for 1 h at 37°C 
with unfixed  cultures  and  tissue  sections or  cultures  fixed  with  3.5% 
paraformaldehyde,  and subsequently the cultures and sections were stained 
with C3d antiserum. 
Monoclonal Antibodies and Antisera 
Monoclonal antibodies to basement membrane-associated antigens were 
produced by hybrids of mouse myeloma cells and spleen cells of mice im- 
munized with a  homogenate of human placental membranes (16). Two 
IgGi (K) antibodies, 3F3 and 4G3,  which displayed  identical  staining pat- 
terns  of all  tissues  tested,  were  used  in  this  study.  Rabbit anti-C3c, 
anti-C3d,  and  anti-C5  antisera  were  from  Behring  Diagnostics,  and 
anti-C3c and anti-C3d antisera were  also purchased from Dako Corp. 
(Santa  Barbara, CA).  The goat anti-C3 antiserum was from Boehringer 
Mannheim Biochemicals (Indianapolis,  IN).  Rabbit anti-human IgM was 
from Antibodies Inc.  (Davis,  CA),  and rabbit anti-human IgG and rabbit 
anti-human IgA were from Behring Diagnostics. 
Enzyme lmmunoassays 
The assays were carried out essentially as described (10). Plastic microtiter 
wells (Flow Laboratories, McLean, VA) were coated with various concentra- 
tions of laminin (Bethesda Research Laboratories, Gaithersburg, MD), type 
IV collagen (Bethesda Research  Laboratories), or fibronectin (11) at room 
temperature overnight.  The washings terminating the coating and antibody 
incubations were carried out in Pi/NaCI containing 0.05%  Tween 20. Hu- 
man C3  (Behring Diagnostics)  was  added at different  concentrations in 
Pi/NaCi and 0.05 % Tween 20. For other binding assays, fresh human citrate 
plasma was prepared in the presence of 10 mM phenylmethylsuifonyl  fluo- 
ride and 10 mM EDTA, and an aliquot was reacted with 0.2 M methylamine 
(Sigma Chemical Co., St.  Louis, MO) for 30 min at 37°C, pH 8, as de- 
scribed (29).  Both untreated and treated aliquots were added to nficrotiter 
wells at different dilutions in Pi/NaCl and 0.05 % Tween 20. Antisera to hu- 
man C3, C3c,  and C3d were diluted in Pi/NaCI and 0.05%  Tween 20 to 
1.  Abbreviations  used  in  this paper:  FITC,  fluorescein  isothiocyanate; 
TRITC,  tetramethylrhodamine isothiocyanate. 
1:1,000-10,000 and incubated in wells. Binding was detected using anti-IgG 
conjugated  with alkaline phosphatase (Sigma Chemical Co.).  All incuba- 
tions were done at 37°C for 2 h. Alkaline phosphatase reaction product was 
measured  with  a  multi-channel photometer  (Titertek  Multiscan,  Flow 
Laboratories,  McLean, VA). All assays were done in duplicates. 
Isolation and Characterization of  C3 and Its Fragments 
The IgG fraction of 3F3 ascitic fluid was precipitated  with 18% Na2SO4, 
collected by centrifugation, redissolved  in 0.1 M NaHCO3, and coupled to 
cyanogen bromide-activated Sepharose (Pharmacia Fine Chemicals). Hu- 
man plasma was pre-run through plain Sepharose  and gelatin-Sepharose 
columns and then applied to a 3F3 antibody column. After washes  with 
Pi/NaCI, the adsorbed material was eluted with 1 M acetic acid.  C3 thus 
isolated was used in experiments confirming the identity of the antigen and 
for some binding experiments. 
Human C3 and C5 were purchased from Behring Diagnostics.  This prep- 
aration of C3 and its fragments (see below) were used for the documented 
binding experiments of this study. After storage, freezing, and thawing, ali- 
quots of the commercial C3 were tested for incorporation of [~C]methyl- 
amine (New England Nuclear) as described by Howard (18) and were found 
to incorporate only minimal amounts of the label (1-3 tool %). A similar 
low level of [14C]methylamine incorporation was exhibited by human C3 
isolated by 3F3 antibody affinity chromatography. Thus, C3 from both these 
sources was considered to be C3(H20) (30).  A high level of [t4C]methyl- 
amine incorporation into C3 (>70 mol %) was obtained when fresh plasma 
was reacted with [L4C]methylamine in 1,000-fold molar excess of plasma 
C3 and the C3(CH3H2) was isolated  by affinity chromatography  on lami- 
nin-Sepharose. 
Human C3 (Behring Diagnostics)  was converted to C3b by light trypsini- 
zation (5 rain at 37°C) as described (29).  The result of the digestion was 
verified  by SDS PAGE of samples under reducing conditions.  To obtain frag- 
ments bearing C3c and C3d determinants, respectively,  the C3 was sub- 
jected to more extensive trypsin digestion as described (4, 26). The course 
of the digestion was followed by SDS PAGE of samples at different time 
points. The material chosen for affinity chromatography  from the prolonged 
trypsin digest did not contain any intact C3 or C3b detectable  by protein 
staining or autoradiography  of ~I-labeled material (14). Purified  rat lami- 
Figure 1. SDS PAGE of protein recognized by the 3F3 and 4G3 anti- 
bodies. Polypeptides were detected by autoradiography (lanes 1-5) 
and  by  Coomassie  Blue  staining  (lanes  6--9).  Polypeptides  im- 
mune  precipitated  by  the  3F3  antibody  from  culture  media 
of  [35S]methionine-labeled subconfluent cultures  of A-431  cells: 
(lane 1 ) unreduced and (lane 2) after reduction. Polypeptides im- 
mune precipitated from the extracted cell layer of [35S]methionine- 
labeled SKLMS-1  cells:  (lane 3)  unreduced,  and  (lane  4)  after 
reduction. (Lane 5) Polypeptides precipitated from the SKLMS-1 
cell layer with an unrelated monoclonal antibody. Polypeptides iso- 
lated from human plasma by 3F3 antibody affinity chromatography: 
(lane 6) unreduced and (lane 7) after reduction. Purified human C3 
(Behring  Diagnostics):  (lane  8)  unreduced,  and  (lane  9)  after 
reduction. 
The Journal of Cell Biology, Volume 103, 1986  1092 Figure 2. Immunological  iden- 
tification  of C3 as the antigen 
recognized by 3F3 antibodies. 
Polypeptides  bound from hu- 
man plasma by 3F3 antibodies 
were  analyzed  upon  SDS 
PAGE, transferred  to nitrocel- 
lulose filter, and reacted with 
rabbit anti-C3c; (lane  1) un- 
reduced  and  (lane  2)  after 
reduction. (Lane 3) The same 
material  as  in  lane  1  im- 
munoblotted  with rabbit  anti- 
C5,  and (lane  4) purified hu- 
man C5 immunoblotted with 
C5  antiserum.  Molecular 
mass  markers  used  include 
myosin (200  kD),  ~galacto- 
sidase  (116 kD),  phosphory- 
lase B (92 kD), BSA (66 kD), 
and ovalbumin  (45 kD). 
nin (12) was coupled  to Sepharose and used to fractionate  radioiodinated  C3 
and both the above  trypsin digests of  radioiodinated C3. The bound  material 
was eluted with 1 M NaC1  and analyzed  on SDS PAGE  followed  by autoradi- 
ography. The eluted material was also immunoprecipitated  by adding pro- 
tein A-Sepharose preincubated with rabbit antiserum to C3c or C3d, and 
after washes the precipitates were analyzed  by SDS PAGE  and autoradiog- 
raphy. 
Results 
Identification of the Antigen 
To identify the antigen recognized by the 3F3 and 4(33 anti- 
bodies,  several  human  tumor  and  normal  cell  lines  were 
metabolically labeled and the culture media immunoprecipi- 
rated for study of secreted radiolabeled proteins.  The same 
major polypeptide chains were precipitated with the 3F3 and 
4G3 antibodies from most of the cell lines studied. The un- 
reduced protein migrated as a single band at 185 kD and was, 
upon reduction, resolved into two major bands at 120 kD and 
75 kD (Fig.  1).  The protein isolated by detergent treatment 
of the cell layer displayed one major band at  185 kD which 
was unaltered after reduction (Fig. 1). Results with the differ- 
ent cell lines  are summarized in Table I. 
The finding of  a hepatoma line among the major producers 
of the  antigen  prompted  a  closer  look  at  known  plasma 
proteins.  A  major  human  plasma  protein  which  bound 
specifically to a 3F3 antibody column, displayed a migration 
pattern in SDS gels identical to that of the cell culture-de- 
rived polypeptides, as well as with human complement com- 
ponent C3 (Fig.  1). After transfer to nitrocellulose filters, the 
protein  isolated  from  human  plasma  by  antibody  affinity 
chromatography  reacted  in  immunoblotting  with  rabbit 
anti-C3c but not with  rabbit anti-C5  (Fig.  2).  The above 
findings established  the identity of the antigen as C3. 
Figure 3. (a and c) Phase-contrast photomicrograph of frozen sections of normal human autopsy kidney. (b and d) Staining of the sections 
with 3F3 antibodies shows a predominantly linear pattern of  fluorescence outlining contours of  the glomerular basement membrane. Mesan- 
gial areas are not stained.  Intimal aspects  of arteriolar walls show bright fluorescence (arrows). Bars, (a and b) 20 I~m; (c and d) 50 ~m. 
Leivo and Engvall C3d Binds to Laminin and Basement Membranes  1093 Figure 4. (a and c) Phase-contrast photomicrographs of sections of term human placenta showing chorionic villi (V) with syncytiotropho- 
blast cells (ST) and maternal decidual tissues (D). Fetal capillary lumina (small arrows) are seen in the villi. (b and d) Indirect immuno- 
fluorescence staining with 3F3 antibodies shows a discontinuous fluorescence outlining trophoblast basement membranes (TBM) of some 
but not all villi, while the fetal capillary basement membranes (small arrows) are not stained. Patches of  amorphous or granular fluorescence 
are seen in the decidua (/arge arrows). Bars, (a and b) 25 ~tm; (c and d) 50 ltm. 
Immunohistochemical Studies 
Reaction of the 3F3 and 4G3 antibodies with tissue sections 
was tested by indirect immunofluorescence using adult hu- 
man and neonatal monkey tissues.  Three adult human kid- 
neys from fresh autopsy cases with no record or findings of 
kidney disease were examined. In two cases, a largely linear 
pattern of bright fluorescence outlining the glomerular base- 
ment membrane was observed (Fig. 3 b). Occasional spotty 
outlines but no general staining of tubular basement mem- 
branes were seen. In the third case, only weak glomernlar 
fluorescence was present. In all three autopsy cases, walls of 
medium-sized arterioli in the kidney were brightly stained 
(Fig. 3 d) while diffuse staining of some vessel walls was ob- 
served in the liver and in other organs (not shown). 
Both human and monkey placentas showed bright fluores- 
cence  with  both  antibodies  in  the  trophoblast  basement 
membranes of the  chorionic  villi  (Fig.  4).  Typically,  the 
staining displayed a linear but frequently interrupted pattern 
giving it a  stitched appearance (Fig. 4).  The proportion of 
villar basement membranes stained varied greatly from one 
placenta to another, ranging from almost 100% to <20%, but 
none of the eight placentas examined was negative. The other 
placental basement membranes (namely, the villar capillary 
basement membrane and the amniotic basement membrane) 
were negative (Fig. 4). No staining of the villar interstitium 
or trophoblast cells was observed. Granular or amorphous 
fluorescence was, however, seen in decidua at the fetomater- 
nal interface in term human placentas (Fig. 4 d).  Decidual 
staining  was  also  present  in  a  lO-wk  pregnant  uterine 
mucosa.  A  basement membrane-type pattern  of staining, 
however, was only found in the glomernlus and the placenta. 
After identification of the antigen recognized by the 3F3 
and 4G3 antibodies as complement component C3, the tissue 
localization of C3, C3c, C3d, C5, IgG, and IgM was studied 
with polyclonal antisera. The C3 antiserum gave a weak lin- 
ear staining of the glomerular basement membrane in the 
cases which were strongly positive with 3F3 and 4G3 anti- 
bodies (Fig. 5 b) and a weak stitched staining of trophoblast 
basement membranes.  The  two C3c  antisera  used  in  this 
study, however, gave no or only faint staining of either base- 
Figure 5. (a, c, and e) Phase-contrast photomicrographs of frozen-sectioned human kidney. (b) Immunofluorescence for C3. Weak fluores- 
cence is seen outlining glomerular basement membranes.  (d) Immunofluorescence for C3c. No fluorescence is seen in the glomeruli or 
other kidney tissues. (f) Immunofluorescence for C3d. A linear-type of staining outlines glomerular basement membranes. (g and h) Im- 
munofluorescence for C3d in frozen-sectioned mouse kidney. (g) Fluorescence outlines tubular basement membranes in arch-like patterns. 
(h) Glomernlar fluorescence has a largely linear pattern. Bars, (a and b) 20 I~m; (c and d) 20 I~m; (e and f) 30 Ilm; (g) 20 I~m;  (h) 40 pro. 
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ings with the C5, IgG, IgA, and IgM antisera varied from 
negative  to  faintly  positive  in  both  the  glomerular  and 
trophoblast basement membranes (not shown). In contrast to 
these, the two C3d antisera gave bright fluorescence in the 
kidney and the placenta in a pattern similar to that of the 3F3 
or 4G3 antibodies (Fig. 5 f). 
To study the degree of similarity in the staining patterns, 
sections of both placenta and kidney were first stained with 
3F3  antibodies and FITC-conjugated anti-mouse IgG and 
then  stained  with  C3d  antiserum  followed  by  TRITC- 
conjugated anti-rabbit IgG.  In such double stainings,  the 
basement membranes in question showed an identical local- 
ization of both TRITC and FITC fluorescence. Moreover, if 
a tissue section was pretreated with C3d antiserum in low di- 
lution (1:10) overnight, and  subsequently stained with the 
3F3 antibodies followed by a mouse IgG-specific FITC con- 
jugate, no FITC fluorescence could be seen. These experi- 
ments indicated that the epitope recognized by the 3F3 anti- 
body lies in immediate proximity to those recognized by the 
C3d antiserum. 
A study of mouse kidneys wa  s undertaken to eliminate the 
possibility that basement membrane-associated C3d was the 
result of (artifactual) complement activation and C3d deposi- 
tion due to blood clotting in human and monkey tissue sam- 
ples. In all four adult mouse kidneys snap-frozen in situ, the 
glomeruli displayed C3d fluorescence with a prominent lin- 
ear component (Fig.  5,  g  and h).  In addition,  prominent 
staining of tubular basement membranes was  seen in this 
species in arch-like or stitched patterns (Fig. 5 g). In con- 
trast, in both newborn monkey and newborn mouse kidney 
no or only faint glomerular C3d fluorescence was observed 
while  the  tubular  basement  membranes  in  the  newborn 
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Figure 6. Binding of human C3 to various solid-phase extracellular 
matrix proteins.  C3 (10 I~g/ml) was added to wells coated with 
different concentrations of proteins tested. Bound C3 was assayed 
using  a  rabbit  C3d  antiserum  followed by  alkaline  phospha- 
tase-conjugated goat anti-rabbit IgG. (o) Mouse laminin (LAb/); 
(o) mouse type IV collagen (C/V); (zx) human plasma fibronectin 
(b-N); (A) BSA, fetuin, or transferrin. 
mouse showed a pattern of C3d fluorescence similar to that 
in the adult mouse kidney (not shown). No or only minimal 
fluorescence for C3c and C5 was found in mouse kidneys. 
In an attempt to examine the nature of the binding of C3d 
in tissues, sections were incubated with 1 M NaCI, 1 M ace- 
tic acid, 4 M KSCN, 6 M guanldine hydrochloride, or 8 M 
urea to remove C3d.  No apparent effect on the intensity of 
C3d fluorescence was seen with  1 M  NaC1 whereas treat- 
ment  with  1  M  acetic acid  removed all  C3d  immunore- 
activity  from  mouse  tubular  basement  membranes  and 
weakened the C3d fluorescence in mouse glomeruli and hu- 
man placenta. Laminin immunoreactivity was unaltered by 
these treatments. No effect  of acid on C3d fluorescence in the 
human kidney was observed. Harsher treatments resulted in 
loss of tissue integrity. 
Binding Studies 
Because of the basement membrane-associated tissue local- 
ization of C3d, the interaction of soluble C3 with solid-phase 
basement  membrane  molecules  was  studied  in  enzyme 
immunoassays and in affinity chromatography on laminin- 
Sepharose. Intact C3 with the properties of C3(H20) and its 
tryptic fragments were used in these studies. 
When C3 was added into wells coated with laminin, type 
IV collagen, or fibronectin, binding to all three proteins oc- 
curred to some extent, but binding to laminin was clearly 
more efficient than binding to type IV collagen or fibronectin 
(Fig. 6). Binding of C3 was first detectable at a laminin coat- 
ing concentration of 30 ng/ml, while binding of C3 to type 
IV collagen or fibronectin only became detectable at 10-fold 
higher coating concentrations. Binding of C3 to bovine se- 
rum albumin (BSA), fetuin, and transferrin was negligible. 
To study the specificity of  the interaction of soluble C3 and 
solid-phase laminin, microtiter wells were coated with low 
amounts (0.2 Ixg/ml) of laminin, and C3 was added together 
with  soluble laminin at different concentrations.  With  in- 
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Figure 7. Inhibition of binding of C3 to solid-phase laminin by solu- 
ble laminin. C3 (2 ~tg/ml) together with different amounts of solu- 
ble mouse laminin (A), human fibronectin (o), or BSA, IgM, or 
transferrin (A) were added into wells coated with mouse laminin 
(0.2 Ixg/ml). Bound C3 was assayed using rabbit C3d antiserum. 
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to the wells decreased progressively (Fig. 7). On the other 
hand, soluble BSA, IgM, or transferrin did not decrease the 
binding of C3 to solid-phase laminin. Increasing concentra- 
tions of soluble fibronectin, however, produced some inhibi- 
tion of the binding of C3 to laminln (Fig. 7) but fibronectin 
was a less efficient inhibitor than laminin. 
The effect of ionic strength on the interaction of C3 and 
laminin was also tested. Increasing concentrations of NaCI 
inhibited a progressively larger proportion of the binding of 
C3 to solid-phase laminin until a maximum of over 90% in- 
hibition was achieved at ~1.0 M  NaCI (Fig. 8). 
The role of the integrity of C3 in binding to laminin was 
studied  by  comparing  the  binding  of C3  from fresh hu- 
man citrate plasma and from methylamine-treated plasma. 
No binding of C3 to laminln took place from fresh plas- 
ma  whereas  efficient binding  was  observed from methyl- 
amine-treated plasma  (Fig.  9).  No binding of C5  or Clq 
was  observed  in  either  case  (Fig.  9).  Also,  isolated 
['4C]methylamine-labeled C3  bound  efficiently to  laminin 
in enzyme immunoassays (not shown). 
The affinity of soluble C3 for solid-phase laminin was also 
tested by passing radioiodinated C3 over laminin coupled to 
Sepharose. Bound material was eluted with 1 M  NaCI and 
subjected  to  SDS  PAGE.  The  eluate  contained  a  large 
proportion of the applied radioactivity, and under nonreduc- 
ing conditions, the eluted material migrated as a single band 
at 185 kD (Fig.  10, lane 1) and at 120 kD and 75 kD after 
reduction. A similar result was obtained when labeled C3b 
was  fractionated on  laminin-Scpharose.  Only  a  minimal 
amount of radioactivity from either preparation bound to a 
similar bed volume of BSA-Sepharose. 
To study which domain(s) of C3 are responsible for the in- 
teraction with laminln, a prolonged trypsin digest of radioio- 
dinated C3 containing no intact C3 or C3b was fractionated 
on laminin-Sepharose, and the bound material was eluted 
1.5 
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,,¢  1.0 
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0.5 
with 1 M NaC1 and analyzed by SDS PAGE. The nonbound 
material contained radioactivity at the position of C3c (140 
kD) and at lower molecular weights (Fig. 10, lane 3). Rela- 
tive to the starting material, radioactivity at the position of 
C3d (35 kD) was decreased or absent in the nonbound mate- 
rial (Fig.  10, compare lanes 2 and 3). The eluate contained 
one radioactive band which migrated at 35 kD (Fig. 10, lane 
4). In immunoprecipitations of the eluate, a single band at 
35  kD  was  precipitated with  C3d  antiserum,  while only 
negligible radioactivity was precipitated with C3c antiserum 
(Fig.  10, lanes 4-6).  Thus, in C3 digests, the C3d domain 
appears to be the main component binding to laminin.  In 
both affinity chromatography and enzyme immunoassay ex- 
periments, however, the C3d fragment bound less efficiently 
to laminin than intact C3 or C3b. 
The interaction of C3 and laminin was also studied using 
cell cultures. Cultures of human PA-1 teratocarcinoma cells, 
which deposit abundant laminin matrices (our unpublished 
observations) but secrete no detectable C3 (Table I), were 
stained in indirect immunofluorescence with C3d antiserum 
to detect if C3 from calf serum had bound to the matrices. 
In other experiments, C3(H20) was added to PA-1 cultures 
or human tissue sections which were then stained with 3F3 
and 4G3 antibodies or C3d antiserum. In these experiments, 
no newly acquired C3d fluorescence was seen in the extracel- 
lular matrices. Also, human cell lines which secrete C3 (Ta- 
ble I) and deposit some extracellular laminin (JAR, BeWo, 
RD) (1, 31) were stained with 3F3 and 4G3 antibodies, but 
no staining  of extracellular matrices was  observed. Obvi- 
ously, interaction of C3 with assembled basement membrane 
matrices does not take place under these conditions. 
1.5 
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Figure 8. Inhibition of binding of C3 to solid-phase laminin by in- 
creased  ionic  strength.  Different concentrations  of NaC1 were 
added to C3 (10 Bg/ml) and incubated in wells coated with mouse 
laminin (e) or BSA (o) (3 Bg/ml). Bound C3 was assayed using 
rabbit C3d antiserum. 
0  10 .3  10  .2 
plasma  concentration 
Figure 9. Comparison of the binding of C3 to solid-phase laminin 
from fresh human plasma (A) and from methylamine-treated fresh 
human plasma (e). Different dilutions of fresh citrate plasma (with 
phenylmethylsulfonyl fluoride and  EDTA) were added  to  wells 
coated with mouse laminin (3 Bg/rnl) or to wells coated with BSA 
(Ix) (3 Mg/ml). Bound C3 was assayed using rabbit C3d antiserum. 
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digest of the labeled C3 on laminin coupled to Sepharose. Bound 
material was eluted with 1 M NaCl, and samples were analyzed by 
SDS PAGE. (Lane I ) Material bound from intact C3, (lane 2) total 
trypsin digest of C3, (lane 3) polypeptides  not bound to laminin, 
(lane 4) polypeptides bound to laminin,  (lane 5) bound polypep- 
tides immunoprecipitated by C3d antiserum,  (lane 6) bound poly- 
peptides immunoprecipitated by C3c antiserum. The exposure time 
of  the autoradiogram of lane 4 is about four times longer than those 
of lanes 1-3. The mobilities of C3 and its fragments, C3c and C3d, 
are marked by arrows. 
Discussion 
The present light microscopic results  show C3d,  a  break- 
down  product  of complement,  outlining  basement  mem- 
branes of the apparently normal autopsy glomerulus and the 
placenta.  This information agrees with earlier clinical and 
autopsy materials which indicate that a minor degree of C3 
immunoreactivity can be demonstrated in glomeruli of up to 
% of clinically normal donor and autopsy kidneys (21, 39). 
When evaluating the biological significance of these results, 
it may be useful to remember that human tissue material, 
when used to study the interaction of circulating proteins and 
filter basement membranes, may be subject to artefactual en- 
trapment of proteins due to alteration of hemodynamic con- 
ditions before fixation (13).  Nevertheless, even under such 
circumstances, a specific deposition of C3d is interesting and 
may disclose molecular interactions operative in pathologi- 
cal conditions. 
The scarce immunoreactivity for C3c and the strong reac- 
tivity for C3d in the present kidney and placenta material 
suggest that only the C3d portions of the molecules are re- 
mined.  The weak staining obtained with the C3  antiserum 
agrees with this interpretation,  since C3c determinants are 
likely to form the major part of the specificities recognized 
by a C3 antiserum.  Furthermore, the absence or negligible 
reactions for IgG, IgA, IgM, and C5 at the basement mem- 
branes of the glomerulus and the placenta suggest that the 
presence of C3d is not due to ongoing local complement acti- 
vation or immune complex deposition. 
It is possible that the basement membrane-associated C3d 
deposits reflect earlier in vivo complement activation or pro- 
teolytic C3 cleavage with deposition of C3b and subsequent 
removal of C3c. The basement membrane specificity of C3d 
deposits, however, suggests that the binding is not solely due 
Table L C3 Immunoprecipitated from Culture Media 
of  Human Cell Lines 
Cell line  Origin  Secretion of C3" 
IMR-32  Adrenal neuroblastoma  - 
FL  Amniotic epithelium  + 
MCF-7  Breast adenocarcinoma  ++ 
MB9812  Bronchogenic carcinoma  - 
A-431  Cervical  carcinoma  ++ 
Caski  Cervical carcinoma  ++ 
SKGIIIa  Cervical carcinoma  ++ 
BeWo  Choriocarcinoma  ++ 
JAR  Choriocarcinoma  ++ 
JEG-3  Choriocarcinoma  + 
HUVEC  Cord endothelium 
RD  Embryonal rhabdomyosarcoma  + 
IMR-90  Embryonic fibroblast  + 
MRC-5  Embryonic fibroblast  + 
WI-38  Embryonic fibroblast  + 
CRL-1573  Embryonic kidney 
5838  Ewing sarcoma  - 
HT-I080  Femoral fibrosarcoma  + 
MB 8387  Fibrosarcoma or osteosarcoma  + 
U-373MG  Glioblastoma  + 
HepG-2  Hepatocellular  carcinoma  ++ 
M-21  Melanoma  + 
PA- 1  Ovarian teratocarcinoma  - 
A204  Rhabdomyosarcoma  - 
SKLMS-I  Vulvar leiomyosarcoma  ++ 
* The relative amount of C3-bound radioactivity precipitated is scored as + or 
++. Absence of such radioactivity under conditions used is scored -. 
to the random reactivity of the thioester linkage of C3d but 
may result from a specific binding affinity. In fact, the pres- 
ent elution studies suggest that some of the deposited C3d 
may be noncovalently bound.  The precise binding  mech- 
anisms of basement membrane-associated C3d  remain to 
be  determined  but  present  in  vitro  results  suggest  that 
C3(H20)  as well as C3b and C3d could also be deposited 
due to interactions with tissue components. 
Blood coagulation in postpartal and postmortal human tis-  i 
sues, due to associated cleavage of complement factors (36); 
might provide an  artifactual  source of reactive C3b.  The  • 
present experiments with in situ frozen mouse tissues indi i 
cate,  however,  that  the  phenomenon  of  basement  mem-i 
brane-associated C3d deposition is not an artifact of blood ,. 
clotting in tissue samples  ..... 
In early  immunohistological  studies,  C3  (determinants)  ~. 
were demonstrated in the trophoblast basement membrane at 
various stages of normal human pregnancy (25,  41).  As the 
placental C3d of our study shows a similar interrupted pat- 
tern of deposition,  it seems likely that the present and the 
previous observations deal with the same phenomenon. Our 
results, however, indicate that only the C3d part of the mole- 
cule is present. The origin and significance of C3d at this lo- 
cation are not clear at present.  Conceivably, the deposited 
C3d  could  be  derived  from  maternal  circulation,  or  be 
secreted locally by macrophage-like Hofbauer cells,  fibro- 
blasts, or trophoblastic cells, as such cells in culture secrete 
C3 (35,  40, our present observations). The fetal circulation 
is a less likely alternative since C3d is not found in the fetal 
capillary  basement  membrane  which  constitutes  the  first 
filtration barrier for fetal plasma proteins. 
The Journal of Cell Biology, Volume 103, 1986  1098 C3d, due to its small size and almost neutral pI (7.5),  is 
among those plasma proteins which could easily enter and 
traverse the glomerular basement membrane under normal 
hemodynamic conditions.  Some of these small molecular 
weight proteins, such as lysozyme and 132-glycoprotein III, 
can also bind to normal glomeruli (5, 6). In the case of  highly 
basic proteins, such as lysozyme (pI 11), binding is thought 
to be due to attraction of the protein to the anionic charges 
of basement membrane heparan sulfate proteoglycan (13). 
More specific mechanisms of binding, however, must be in- 
volved when neutral (e.g., C3d) or acidic (e.g.,  132-glyco- 
protein  III)  small  molecular weight proteins  bind to  the 
glomerulus. A comparison of the binding behavior of C3d 
(Mr  35,000;  pI 7.5;  plasma concentration 8  lxg/ml) made 
with three other plasma proteins of comparable size, isoelec- 
tric point, and plasma concentration showed that none of 
these three, 132-glycoprotein I (Mr 48,000;  pI 6.25; plasma 
concentration 200  lxg/ml),  C3 activator (132II) (Mr 60,000; 
pI 6.0; plasma concentration 120-300 gg/ml), or 132-micro- 
globulin  (Mr  12,000; pI  5.8;  plasma  concentration  1.5 
lxg/ml) was found by immunofluorescence in the glomeruli 
of normal postmortem kidneys (6; our observations). Thus, 
a  study of the binding specificities of C3d appeared war- 
ranted. 
As C3d antibodies specifically outlined basement mem- 
brane contours in tissues, enzyme immunoassays were un- 
dertaken to study the interaction of C3 and its fragments with 
various basement membrane proteins. C3 bound particularly 
efficiently to laminin, while weaker interactions were ob- 
served with type IV collagen and fibronectin. The binding 
of C3 and the fragments C3c and C3d to fibronectin has been 
reported previously (15). Binding of C3 to solid-phase lami- 
nin could be inhibited by excess soluble laminin, indicating 
that the interaction also takes place in fluid phase and that 
it is not dependent on conformational changes of laminin in- 
duced by adsorption onto plastic. Partial cross-inhibition by 
fibronectin suggests that the sites in C3d interacting with 
laminin and fibronectin may be related. 
Information about the domain of  C3 responsible for the in- 
teraction with laminin was obtained by studying the binding 
of iodinated C3 fragments to laminin-Sepharose. Prolonged 
trypsin digestion of C3 yields a large (120 kD) and a small 
(35  kD)  fragment containing C3c and C3d determinants, 
respectively. Such fragments, used in the present study, dis- 
play an approximate correspondence to  the physiological 
counterparts  released  during  C3  activation.  Our  affinity 
chromatography results indicated that, of the different frag- 
ments present  in  digestion mixtures,  only C3b  and  C3d 
bound to laminin-Sepharose, while C3c did not. This local- 
izes the binding site to the C3d fragment which is contained 
in C3b. 
Interestingly, no binding of native C3 to laminin was ob- 
served from fresh human plasma whereas strong binding 
took place from methylamine-treated plasma. Methylamine, 
when  reacting  with  the  internal  thioester  linkage of C3, 
causes a conformational change of the molecule such that 
C3(CH3NH2)  functionally  resembles  C3(H20)  and  C3b 
(29, 30).  In the present study, the binding of C3(CH3NH2), 
C3(H20), C3b(H20), and C3d to laminin indicates that the 
interaction is not dependent on the cross-linking capabilities 
of the internal thioester linkage in C3. Rather, it seems that 
the conformational state of C3 is essential for the interaction. 
Conformational  factors  could  also  explain  the  apparent 
differences in the binding affinities to laminin of C3(H20) 
and C3d. 
Inhibition of the binding of C3 to laminin by high salt con- 
centrations reveals the importance of ionic forces in the inter- 
action. The charge properties of C3d were investigated using 
a hydrophilicity plot based on the amino acid sequence of 
C3d (9). This analysis, however, did not disclose any major 
hydrophilic domains which could provide an obvious expla- 
nation for the interaction.  The binding of C3  to laminin, 
then, may depend on more specific ionic compatibility. 
Lack of the binding of exogenous C3 to cell culture ma- 
trices and tissue sections could imply that the binding sites 
of C3 are not readily available in assembled matrices. An 
interesting  direction  for  future  research  is  to  determine 
whether C3 present in immune complexes can also bind to 
laminin, as has been suggested for the interaction of Clq and 
laminin (3). If indeed operative in human disease, the inter- 
action of C3 and laminin could also have significance in dis- 
eases like IgA nephropathy and membranoproliferative glo- 
merulonephritis where the alternative complement pathway 
is activated at the glomerular basement membrane (34). 
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